Navigation Links
WaferGen Bio-systems Reports Completion of $15 Million Private Placement Transaction
Date:10/2/2013

FREMONT, Calif., Oct. 2, 2013 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today that it has completed a private placement to accredited investors of $15,037,500 of units consisting of shares of common stock, shares of Series 1 convertible preferred stock and warrants to purchase shares of common stock.

As previously announced, at the initial closing of the offering on August 27, 2013, the Company sold $13,668,500 of units for net proceeds of approximately $12,300,000.  At a subsequent closing on September 30, 2013, the Company sold an additional $1,369,000 of units for net proceeds of approximately $1,200,000.  In the private placement, the Company issued a total of 5,893,750 shares of common stock, 646 shares of Series 1 preferred stock (with a $0.001 per share liquidation preference and convertible into a total of 1,625,000 shares of Common Stock) and 3,759,379 five-year warrants with a $2.60 exercise price.  For additional details regarding the private placement, please see the current report on Form 8-K filed by the Company on August 28, 2013.

National Securities Corporation acted as sole placement agent in connection with the Offering and received compensation of approximately $1,300,000 cash and warrants to purchase 35.88 units at an initial exercise price of $50,000 per unit.

As previously reported, immediately prior to the initial closing of the private placement, the Company completed a restructuring transaction pursuant to which the Company exchanged shares of Series A-1 preferred stock with a liquidation preference of approximately $17.1 million, convertible notes with a principal amount of approximately $17.1 million and warrants exercisable for 565,180 shares of common stock for 2,987 shares of Series 1 preferred stock (with a $0.001 per share liquidation preference and convertible into a total of 7,513,372 shares of Common Stock), 1,067,317 shares of common sto
'/>"/>

SOURCE WaferGen Bio-systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WaferGen Bio-systems Announces New Funding from Private Placement
2. WaferGen Launches SmartChip TE - A Novel Target Enrichment Solution for Next-Gen Sequencing (NGS) Aimed at Clinical Applications
3. WaferGen Bio-systems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
4. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
5. Moleculin Reports Positive Data From Controlled Study of Novel Topical Psoriasis Treatment
6. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
7. Allied Healthcare Products Reports Loss On Sales Decline
8. TPI Reports Fiscal Year 2013 Financial Results
9. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Substantial Reductions of Triglycerides and Apoc-III in Patients with Familial Chylomicronemia
10. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
11. Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... YORK , Jan. 15, 2014 /PRNewswire/ ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ... Summary,Although the past decade has ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an ... for patients to self-inject prescription drugs in the large ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... expected to grow to $220B by 2018, according to ... type of injector that does not exist today for ...
(Date:1/14/2014)... 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), a ... it acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... terms of the acquisition were not disclosed. ... providing a wide range of sleep, mobility, and respiratory products ... and Pittsburgh markets. Progressive was founded ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... 2007 - A new study published,in the ... Neurology indicates,that a treatment from Medtronic, Inc. ... improves their quality of life and is,cost-effective ... of this Medtronic-sponsored study should,expand access to ...
... they are outraged,over recent media coverage about ... treat a hormone deficiency often associated,with aging., ... -- The adult,use of human growth hormone ... recent New,York Times article about the founders ...
Cached Medicine Technology:Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 2Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 4Doctors Outraged Over Growth Hormone Controversy 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... ... 2009 -- Bariatric Advantage, a Division of Catalina Lifesciences, Inc. Announces The Promotion of ... ... Advantage, a Division of Catalina Lifesciences, Inc. Announces The Promotion of Bret Petkus to ...
... believes more research is needed , WEDNESDAY, Dec. 30 (HealthDay ... to ease hot flashes and other uncomfortable symptoms in women ... the needle treatment may boost the patient,s sex drive and ... shows you that acupuncture is a good option for these ...
... , ALISO VIEJO, Calif., Dec. 30 Valeant Pharmaceuticals International ... Food and Drug Administration (FDA) has accepted for review the ... drug retigabine, a neuronal potassium channel opener for the adjunctive ... addition, the European Medicines Agency (EMEA) confirmed on November 17, ...
... , FORT LAUDERDALE, Fla., Dec. 30 eDiets.com, Inc. ... fitness and healthy lifestyle solutions, today announced that long-time eDiets.com member ... when she went from weighing 326 pounds over two years ago ... PEOPLE,s upcoming January 11th "Half Their Size" issue which will be ...
... , MINNEAPOLIS, Dec. 30 Happy Hour Effect(TM), a ... employment stress and promote work/life balance, is pleased to announce ... in time for our 2010 New Year,s resolutions. ... consists of an easy and fun process that guides users ...
... , ATLANTA, Dec. 30 Martin Luther King Jr. weekend ... Bid Whist Tournament with a Qualifying Tournament and Health Fair in ... 7 NO! Players of Atlanta, the original hosts of the Bid ... in the Black community. The Health Fair, in partnership with local ...
Cached Medicine News:Health News:Bariatric Advantage, a Division of Catalina Lifesciences, Inc. Announces Appointment of Bret Petkus to Vice-President of North American Sales. 2Health News:Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer Patients 2Health News:FDA Accepts NDA Filing for Retigabine 2Health News:eDiets.com(R) Member Loses Over 150 lbs, to be Featured in PEOPLE Magazine and on The TODAY Show 2Health News:New Year's Resolutions Just Got Easier - Happy Hour Effect LLC to Launch 'The Happy Hour Effect(TM) Balance Plan' in 2010 2Health News:New Year's Resolutions Just Got Easier - Happy Hour Effect LLC to Launch 'The Happy Hour Effect(TM) Balance Plan' in 2010 3Health News:The Black AIDS Institute Kicks Off Its National Platform to Build Black AIDS Awareness in Atlanta, GA 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: